|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 15 May 2007
doi: 10.1242/jcs.03456
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |


1 Center for Oncology and Cell Biology, The Feinstein Institute for Medical Research at North Shore-LIJ, North Shore University Hospital, Manhasset, NY 11030, USA
2 Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
3 Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
4 Department of Surgery, North Shore University Hospital, Manhasset, NY 11030, USA
Author for correspondence (e-mail: msymons{at}nshs.edu)
Accepted 15 March 2007
Wrch-1 (Wnt-regulated Cdc42 homolog) is a new member of the Rho family that was identified as a gene transcriptionally upregulated by Wnt-1. Wrch-1 has no detectable GTPase activity and displays very high intrinsic guanine nucleotide exchange, implying that it is constitutively GTP-bound. The biological functions of Wrch-1 largely remain to be characterized. Here, we report that Wrch-1 prominently localizes to focal adhesions. Depletion of Wrch-1 by small interfering RNA increases focal adhesion formation, whereas Wrch-1 overexpression disassembles focal adhesions. Wrch-1 depletion inhibits myosin-light-chain phosphorylation, which in turn leads to an increase in the number of focal adhesions and inhibits cell migration in response to wound healing. Depletion of Wrch-1 also inhibits Akt and JNK activation. Although pharmacological inhibitors of Akt and JNK inhibit cell migration, they do not affect focal adhesions. Thus, our data suggest that Wrch-1 regulates cell migration by multiple mechanisms: on the one hand Wrch-1 controls focal adhesions by regulating myosin light chain and on the other hand Wrch-1 stimulates the activation of Akt and JNK.
Key words: Wrch-1, Rho, Focal adhesion, Cell migration, Myosin
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
D. C. Brady, J. K. Alan, J. P. Madigan, A. S. Fanning, and A. D. Cox The Transforming Rho Family GTPase Wrch-1 Disrupts Epithelial Cell Tight Junctions and Epithelial Morphogenesis Mol. Cell. Biol., February 15, 2009; 29(4): 1035 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schlessinger, A. Hall, and N. Tolwinski Wnt signaling pathways meet Rho GTPases Genes & Dev., February 1, 2009; 23(3): 265 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Jonassen, J. San Agustin, J. A. Follit, and G. J. Pazour Deletion of IFT20 in the mouse kidney causes misorientation of the mitotic spindle and cystic kidney disease J. Cell Biol., November 3, 2008; 183(3): 377 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Mruk, B. Silvestrini, and C. Y. Cheng Anchoring Junctions As Drug Targets: Role in Contraceptive Development Pharmacol. Rev., June 1, 2008; 60(2): 146 - 180. [Abstract] [Full Text] [PDF] |
||||